Polymer Beadlet Sustained Release via Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Many dietary supplements suffer from low bioavailability and rapid absorption, leading to unstable and unsustainable increases in blood levels, which can overwhelm cellular transport mechanisms and result in excretion rather than targeted absorption.
Innovation Solution
A polymer beadlet composition is developed, where each beadlet consists of a shell made from a combination of materials such as Gum Arabic, Microcrystalline cellulose, Hydroxypropyl methylcellulose, glycerol, γ-cyclodextrin, ethyl cellulose, and metal halide salts, with the active ingredient dispersed within the shell, allowing for sustained release over 8-24 hours.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If dietary supplements are taken in conventional forms, then absorption occurs rapidly, but bioavailability is low and blood levels are unstable
Solution Approach 1:
The supplement is divided into multiple beadlets, each containing a portion of the active ingredient. This segmentation allows for controlled release over time, preventing rapid absorption while maintaining stable blood levels. The beadlets are designed to dissolve at different rates, creating a sustained release profile that improves both bioavailability and stability.
Solution Approach 2:
The patent modifies physical parameters of the supplement by creating beadlets with specific size distributions (500-2000 μm diameter) and controlling the ratio of different polymer materials. These parameter changes enable controlled dissolution rates that optimize absorption while maintaining stability, directly addressing the contradiction between rapid absorption and stable bioavailability.
2Quantity of substance
If high doses of dietary supplements are taken to achieve sustained increase, then absorption capacity is overwhelmed, but excretion increases instead of targeted absorption
Solution Approach 1:
By segmenting the total supplement dose into multiple beadlets with different dissolution rates, the system prevents transporter saturation that would occur with single high-dose administration. The slower-releasing beadlets maintain steady blood concentrations within transporter capacity, while faster-releasing beadlets ensure complete absorption of the total dose over time.
Solution Approach 2:
The beadlet formulation provides continuous release of the active ingredient over extended periods (8-24 hours), maintaining blood concentrations within the optimal range for transporter-mediated absorption. This continuous action prevents the spike-and-excrete cycle that occurs with conventional high-dose administration.
3Ease of manufacture
If conventional supplement formulations are used, then manufacturing is simple, but controlled release is not achieved
Solution Approach 1:
The beadlets are formulated as composite structures combining multiple polymer materials (gum arabic, microcrystalline cellulose, hydroxypropyl methylcellulose, glycerol, γ-cyclodextrin, ethyl cellulose) with different dissolution characteristics. This composite approach enables controlled release over 8-24 hours while maintaining manufacturability through a single extrusion and drying process.
Solution Approach 2:
Different regions of the beadlet structure have different dissolution rates, with some beadlets designed to dissolve faster than others. This local quality variation within the beadlet population creates a distributed release profile that extends duration of action while keeping the overall manufacturing process simple.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer beadlet composition enhances the bioavailability and stability of dietary supplements by providing a controlled release of the active ingredient, reducing excretion and increasing absorption at targeted locations in the body, thereby improving efficacy and compliance with dosing regimens.
Implementation Method 1
the active is dispersed within the polymer beadlet shell
Implementation Method 2
providing a controlled release of the active ingredient, reducing excretion and increasing absorption
Implementation Method 3
the active is dispersed within the polymer beadlet shell
Data Source
AI summary
A composition for sustained release of an active comprising: a plurality of beadlets, wherein each of the plurality of beadlets comprises: a polymer beadlet shell, wherein the active is dispersed within the polymer beadlet shell, the polymer beadlet shell comprises: gum arabic; microcrystalline cellulose (MCC); hydroxypropyl methylcellulose (HPMC); glycerol; γ-cyclodextrin; ethyl cellulose; and one or more metal halide salts.